Fetus
Continuous Electronic Fetal Monitoring
search
Continuous Electronic Fetal Monitoring
, CEFM
See Also
Fetal Heart Tracing
Structured Intermittent Auscultation
(SIA)
Indications
High risk pregnancy (see efficacy below)
See
Peripartum Risk to the Fetus
Antepartum factors
Conditions affecting placental insufficiency
Known fetal anomaly
Maternal
Preeclampsia
or
Gestational Hypertension
Maternal
Type 1 Diabetes Mellitus
Fetal Growth Retardation
suspected
Intrapartum factors
Meconium present
Tachysystole
Intrauterine Infection
Vaginal Bleeding
Uterine stimulant (i.e.
Oxytocin
) use for
Labor Induction
or augmentation
Low risk patient with concerning on
Structured Intermittent Auscultation
(SIA)
Irregular
Fetal Heart Rate
Fetal Tachycardia
(>160 bpm for >10 minutes)
Fetal Bradycardia
(<110 bpm for >10 minutes)
Recurrent fetal decelerations after contractions (>50% of contractions)
Prolonged deceleration (2-10 minutes)
External monitoring is not possible
Maternal body habitus
Fetal Position
interferes with monitoring
Adverse Effects
See Efficacy below (including
False Positive Rate
)
Requires
Amniotomy
and increased risk of
Chorioamnionitis
, vertical transmission HSV and
Viral Hepatitis
Technique
Intrauterine scalp electrode placement
Intrauterine pressure catheter placement
Efficacy
Continuous Electronic Fetal Monitoring (CEFM)
CEFM does not significantly improve fetal outcome
Only measurable benefits
Fewer
Neonatal Seizure
s
Good tracing is reassuring for good outcome
No benefit in
APGAR Score
s
No decrease in NICU admissions
No change in perinatal death rate
No reduction in
Cerebral Palsy
Non-reassuring tracing does not predict bad outcome
False Positive Rate
99.8% if ominous tracing
Late Deceleration
s
Decreased variability
CEFM increases the risk of surgical intervention (
False Positive
for fetal acidosis in two thirds of cases)
Increases ceserean rate by 20%
Increases operative
Vaginal Delivery
rate
Consider
Informed Consent
for CEFM
CEFM may be indicated in high risk pregnancies
Consider intermittent monitoring if low risk
References
Alfirevic (2017) Cochrane Database Syst Rev (1):CD006066 [PubMed]
Arnold (2020) Am Fam Physician 102(3): 158-67 [PubMed]
Devane (2017) Cochrane Database Syst Rev (1):CD005122 [PubMed]
Luthy (1987) Obstet Gynecol 69(5):687-95 [PubMed]
Leveno (1986) N Engl J Med 315(10):615-19 [PubMed]
Type your search phrase here